Moxifloxacin contains moxifloxacin, a fourth-generation fluoroquinolone antibiotic used to treat a range of bacterial infections including respiratory tract infections, skin and soft tissue infections, and intraocular infections. It works by inhibiting bacterial DNA replication enzymes, leading to bacterial cell death. Always use Moxifloxacin exactly as directed by your doctor.

Moxifloxacin contains moxifloxacin, a fourth-generation fluoroquinolone antibiotic with broad-spectrum activity against Gram-positive, Gram-negative, atypical and anaerobic bacteria.

It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription and repair, which may reduce the likelihood of resistance compared to earlier fluoroquinolones.

Its broad coverage and good tissue penetration make it useful in conditions such as community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, complicated skin and intra-abdominal infections, and ophthalmic infections when used as eye drops.

The uses of Moxifloxacin are as follows:

Community-acquired pneumonia

Treats bacterial pneumonia acquired outside hospital settings, including atypical organisms such as Mycoplasma and Chlamydophila.

Acute bacterial exacerbation of chronic bronchitis

Used for bacterial flare-ups in patients with chronic bronchitis.

Complicated skin and soft tissue infections

Effective in deeper or more severe skin infections requiring broad-spectrum cover.

Intra-abdominal infections

Used as part of treatment for complicated infections within the abdominal cavity.

Bacterial conjunctivitis and ocular infections

Ophthalmic formulations treat bacterial eye infections.

Tuberculosis (second-line use)

May be used in multidrug regimens for drug-resistant tuberculosis under specialist supervision.

Here are the benefits of Moxifloxacin:

• Broad-Spectrum Activity: Covers Gram-positive, Gram-negative, atypical, and anaerobic organisms, making it effective across a wide range of infections.

• Dual Enzyme Inhibition: Targeting both DNA gyrase and topoisomerase IV reduces the likelihood of resistance development.

• Good Tissue Penetration: Achieves high concentrations in lung, skin, and abdominal tissues, enhancing efficacy at infection sites.

• Once-Daily Dosing: Convenient dosing schedule supports treatment adherence.

• Effective Against Atypical Organisms: Covers organisms such as Mycoplasma, Legionella, and Chlamydophila that are not targeted by many other antibiotics.

Like all medicines, Moxifloxacin may cause side effects in some individuals.

Common Side Effects

• Nausea: Mild gastrointestinal upset is the most commonly reported side effect.

• Diarrhoea: Some individuals may experience loose stools during treatment.

• Headache: Mild headache may develop during the course of treatment.

• Dizziness: Some patients report mild light-headedness.

Uncommon Side Effects

• Altered Liver Enzymes: Mild transient elevations in liver function tests may occur.

• Skin Rash: Mild hypersensitivity reactions affecting the skin may develop.

• Insomnia: Sleep disturbance has been reported in some patients.

Serious Side Effects (Require Immediate Medical Attention)

• QT Interval Prolongation: Moxifloxacin may prolong cardiac electrical conduction, increasing the risk of serious arrhythmias.

• Tendon Rupture: Fluoroquinolones are associated with tendinitis and tendon rupture, particularly of the Achilles tendon.

• Clostridium difficile Colitis: Severe or persistent diarrhoea during or after treatment may indicate antibiotic-associated colitis.

• Severe Allergic Reaction: Swelling, difficulty breathing, or widespread rash requires urgent medical care.

• Peripheral Neuropathy: Numbness, tingling, or weakness in the limbs should be reported promptly.

• Always consult your doctor if side effects persist or worsen.

To ensure safe use:

• Use exactly as prescribed and complete the full course even if symptoms improve.

• Oral tablets may be taken with or without food.

• Take at the same time each day for consistent blood levels.

• Avoid taking with antacids, iron, or calcium supplements within several hours of dosing.

• Eye drops should be instilled as directed with clean hands.

Moxifloxacin inhibits two bacterial enzymes, DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication, transcription, repair, and recombination. Inhibiting both enzymes simultaneously prevents bacteria from copying their genetic material, leading to rapid bacterial cell death.

This dual-target mechanism reduces the likelihood of resistance emerging through a single mutation, contributing to the sustained effectiveness of moxifloxacin across a broad range of bacterial pathogens.

A few practical measures can help ensure safe and effective use of Moxifloxacin:

• Complete the full course: Stopping early may allow bacteria to persist and increase resistance risk.

• Avoid antacids and mineral supplements near dosing: Products containing magnesium, aluminium or calcium, as well as iron or zinc, can reduce absorption if taken together.

• Report tendon pain promptly: Pain or swelling, especially in the Achilles tendon, should be reported immediately and activity reduced.

• Inform your doctor of heart conditions: The risk of QT prolongation may be higher in those with existing cardiac conditions or on certain medicines.

• Protect skin from sun exposure: Photosensitivity may occur; use sunscreen and limit prolonged sun exposure during treatment.

• Store at room temperature: Keep away from heat, moisture, and direct sunlight.

• Keep in original packaging: Protects tablets and eye drops from light and humidity.

• Eye drops: Once opened, observe the discard period stated on the label.

• Keep out of reach of children: Store safely to prevent accidental ingestion.

• Check expiry before use: Do not use after the expiry date.

• Avoid antacids and mineral supplements near dose time: Magnesium, aluminium, calcium, iron, and zinc significantly reduce oral absorption when taken simultaneously.

• Avoid excessive alcohol: May worsen dizziness and central nervous system effects.

• No significant restriction with food: Tablets may be taken with or without meals.

• QT-Prolonging Medicines: Combined use with antiarrhythmics, antipsychotics, or other QT-prolonging agents significantly increases arrhythmia risk.

• Antacids and Mineral Supplements: Reduce oral absorption of moxifloxacin and should be separated by several hours.

• Anticoagulants (Warfarin): Moxifloxacin may enhance anticoagulant effects, requiring closer INR monitoring.

• Antidiabetic Medicines: Blood glucose disturbances may occur, requiring monitoring adjustments.

• Corticosteroids: Combined use increases the risk of tendon rupture, particularly in older patients.

• Cardiac Arrhythmias and QT Prolongation: Moxifloxacin should be avoided in patients with known QT prolongation or those taking other QT-prolonging medicines.

• Tendon Disorders: Risk of tendinitis and rupture is increased in patients with a history of tendon problems or those on corticosteroids.

• Epilepsy and CNS Disorders: Fluoroquinolones may lower the seizure threshold in susceptible individuals.

• Myasthenia Gravis: Fluoroquinolones may worsen neuromuscular transmission and are generally avoided in myasthenia gravis.

• Severe Hepatic Impairment: Use requires caution as moxifloxacin is primarily metabolised hepatically.

Usually administered as a single daily oral dose or as directed by your doctor. Eye drop dosing frequency varies by indication.

If a dose is missed, take it as soon as remembered, but do not double the dose to make up for a missed one.